MERCYONE - NEWTON MEDICAL CENTER — History
CCN 160032 | 3-year financial timeline | COVID resilience: 40/100
🛡️ Public data only — no PHI permitted on this instance.
$35M
Latest Revenue (FY2022)
+0.1%
Revenue CAGR (3yr)
-17.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $34M | $37M | $35M | -6.4% | +0.1% |
| Operating Expenses | $39M | $44M | $41M | -7.5% | +2.6% |
| Operating Margin | -11.7% | -18.9% | -17.4% | +7.9% | +0.0% |
| Net Income | $-4M | $-7M | $-6M | +13.8% | +0.0% |
| Licensed Beds | 48 | 48 | 48 | +0.0% | +0.0% |
| Total Patient Days | 2,805 | 2,945 | 2,529 | -14.1% | -5.0% |
| Medicare Day % | 40% | 42% | 38% | -8.4% | -2.5% |
| Medicaid Day % | 16% | 17% | 20% | +19.9% | +14.8% |
COVID Impact & Recovery
Resilience Score: 40/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +0.2% ($34M → $35M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+0.1%
This Hospital
+7.6%
State Avg
Latest Margin
-17.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $35M | -20.2% |
| FY2024 (proj) | $35M | -23.1% |
| FY2025 (proj) | $35M | -25.9% |